Autoimmune encephalitis update

Neuro-Oncology

Volumn 16, Issue 6, 2014, Pages 771-778

  Dalmau, Josep ^a   Rosenfeld, Myrna R ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

antibodies; autoimmune; encephalitis; paraneoplastic; synaptic antigens

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; AMPHIPHYSIN; DIPEPTIDYL PEPTIDASE LIKE PROTEIN 6; GLUTAMATE DECARBOXYLASE; GLYCINE; LEUCINE RICH GLIOMA INACTIVATED 1; LEUCINE RICH REPEAT KINASE 2; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN; RECEPTOR; UNCLASSIFIED DRUG; ANTIBODY;

AMNESIA; ANTI N METHYL D ASPARTATE RECEPTOR ENCEPHALITIS; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE ENCEPHALITIS; CANCER IMMUNOTHERAPY; CHOREOATHETOSIS; CONFUSION; DEMYELINATING DISEASE; DYSKINESIA; ENCEPHALITIS; EPIDEMIC ENCEPHALITIS; EPILEPTIC STATE; HALLUCINATION; HERPES SIMPLEX ENCEPHALITIS; HUMAN; PARANEOPLASTIC ENCEPHALOMYELITIS; PARANEOPLASTIC NEUROPATHY; PARANEOPLASTIC SENSORY NEURONOPATHY; PATHOGENESIS; PERSONALITY DISORDER; SEIZURE; SYNAPTIC TRANSMISSION; BRAIN DISEASES; HASHIMOTO DISEASE; IMMUNOLOGY; METABOLISM;

ANTIBODIES; BRAIN DISEASES; HASHIMOTO DISEASE; HUMANS;

EID: 84901021047     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nou030     Document Type: Article

References (59)

1. Lancaster E, Dalmau J. Neuronal autoantigens-pathogenesis, associated disorders and antibody testing. Nat Rev Neurol. 2012; 8(7):380-390.
2. Darnell RB, Posner JB. Paraneoplastic Syndromes. New York: Oxford; 2011.
3. Bernal F, Graus F, Pifarre A, et al. Immunohistochemical analysis of anti-Hu-associated paraneoplastic encephalomyelitis. Acta Neuropathol (Berl). 2002;103(5):509-515.
4. Albert ML, Darnell JC, Bender A, et al. Tumor-specific killer cells in paraneoplastic cerebellar degeneration. Nat Med. 1998;4(11): 1321-1324.
5. Lancaster E, Martinex-Hernandez E, Dalmau J. Encephalitis and antibodies to synaptic and neuronal cell surface proteins. Neurology. 2011;77(2):179-189.
6. Hughes EG, Peng X, Gleichman AJ, et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci. 2010; 30(17):5866-5875.
7. Saiz A, Blanco Y, Sabater L, et al. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain. 2008; 131(10):2553-2563.
8. Pittock SJ, Lucchinetti CF, Parisi JE, et al. Amphiphysin autoimmunity: paraneoplastic accompaniments. Ann Neurol. 2005;58(1):96-107.
9. Ishida K, Mitoma H, Mizusawa H. Reversibility of cerebellar GABAergic synapse impairment induced by anti-glutamic acid decarboxylase autoantibodies. J Neurol Sci. 2008;271(1-2):186-190.
10. Burton AR, Vincent E, Arnold PY, et al. On the pathogenicity of autoantigen-specific T-cell receptors. Diabetes. 2008;57(5): 1321-1330.
11. Rosenfeld MR, Dalmau J. Diagnosis and management of paraneoplastic neurologic disorders. Curr Treat Options Oncol. 2013;14(4):528-538.
12. Blaes F, Tschernatsch M. Paraneoplastic neurological disorders. Expert Rev Neurother. 2010;10(10):1559-1568.
13. Didelot A, Honnorat J. Update on paraneoplastic neurological syndromes. Curr Opin Oncol. 2009;21(6):566-572.
14. Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12(2):157-165.
15. Kayser MS, Titulaer MJ, Gresa-Arribas N, et al. Frequency and characteristics of isolated psychiatric episodes in anti-N-methyld-aspartate receptor encephalitis. JAMA Neurol. 2013;70(9): 1133-1139.
16. Armangue T, Titulaer MJ, Malaga I, et al. Pediatric anti-N-methyl-D- aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients. J Pediatr. 2013; 162(4):850-856.
17. Titulaer MJ, McCracken L, Gabilondo I, et al. Late-onset anti-NMDA receptor encephalitis. Neurology. 2013;81(12):1058-1063.
18. Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7(12):1091-1098.
19. Gresa-Arribas N, Titulaer MJ, Torrents A, et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol. 2013;13(2):167-177.
20. Lai M, Hughes EG, Peng X, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol. 2009; 65(4):424-434.
21. Graus F, Boronat A, Xifro X, et al. The expanding clinical profile of anti-AMPA receptor encephalitis. Neurology. 2010;74(10): 857-859.
22. Bataller L, Galiano R, Garcia-Escrig M, et al. Reversible paraneoplastic limbic encephalitis associated with antibodies to the AMPA receptor. Neurology. 2010;74(3):265-267.
23. Lancaster E, Lai M, Peng X, et al. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol. 2010;9(1):67-76.
24. Boronat A, Sabater L, Saiz A, et al. GABA(B) receptor antibodies in limbic encephalitis and anti-GAD associated neurological disorders. Neurology. 2011;76(9):795-800.
25. Hoftberger R, Titulaer MJ, Sabater L, et al. Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients. Neurology. 2013;81(17):1500-1506.
26. Sabater L, Titulaer M, Saiz A, et al. SOX1 antibodies are markers of paraneoplastic Lambert Eaton myasthenic syndrome. Neurology. 2007;70(12):4260-4267.
27. Lai M, Huijbers MG, Lancaster E, et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol. 2010;9(8):776-785.
28. Irani SR, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain. 2010; 133(9):2734-2748.
29. Andrade DM, Tai P, Dalmau J, et al. Tonic seizures: a diagnostic clue of anti-LGI1 encephalitis. Neurology. 2011;76(15):1355-1357.
30. Fukata Y, Lovero KL, Iwanaga T, et al. Disruption of LGI1-linked synaptic complex causes abnormal synaptic transmission and epilepsy. Proc Natl Acad Sci USA. 2010;107(8):3799-3804.
31. Fukata Y, Adesnik H, Iwanaga T, et al. Epilepsy-related ligand/receptor complex LGI1 and ADAM22 regulate synaptic transmission. Science. 2006;313(5794):1792-1795.
32. GuW, Brodtkorb E, Steinlein OK. LGI1 is mutated in familial temporal lobe epilepsy characterized by aphasic seizures. Ann Neurol. 2002; 52(3):364-367.
33. Kalachikov S, Evgrafov O, Ross B, et al. Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features. Nat Genet. 2002;30(3):335-341.
34. Lancaster E, Huijbers MG, Bar V, et al. Investigations of Caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol. 2011; 69(2):303-311.
35. Gregor A, Albrecht B, Bader I, et al. Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1. BMC Med Genet. 2011;12:106.
36. Verkerk AJ, Mathews CA, Joosse M, et al. CNTNAP2 is disrupted in a family with Gilles de la Tourette syndrome and obsessive compulsive disorder. Genomics. 2003;82(1):1-9.
37. Petit-Pedrol M, Armangue T, Peng X, et al. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABA(A) receptor: a case series, characterization of the antigen, and analysis of the effects of antibodies. Lancet Neurol. 2014;13(3):276-286.
38. Boronat A, Gelfand JM, Gresa-Arribas N, et al. Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels. Ann Neurol. 2013;73(1):120-128.
39. Nadal MS, Ozaita A, Amarillo Y, et al. The CD26-related dipeptidyl aminopeptidase-like protein DPPX is a critical component of neuronal A-type K+ channels. Neuron. 2003;37(3):449-461.
40. De Camilli P, Thomas A, Cofiell R, et al. The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of stiff-man syndrome with breast cancer. J Exp Med. 1993;178(6): 2219-2223.
41. McKeon A, Robinson MT, McEvoy KM, et al. Stiff-man syndrome and variants: clinical course, treatments, and outcomes. Arch Neurol. 2012;69(2):230-238.
42. Raju R, Foote J, Banga JP, et al. Analysis of GAD65 autoantibodies in stiff-person syndrome patients. J Immunol. 2005;175(11): 7755-7762.
43. Hutchinson M, Waters P, McHugh J, et al. Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody. Neurology. 2008;71(16):1291-1292.
44. Mas N, Saiz A, Leite MI, et al. Anti-glycine receptor encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry. 2011;82(12): 1399-1401.
45. Lancaster E, Martinez-Hernandez E, Titulaer MJ, et al. Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome. Neurology. 2011;77(18):1698-1701.
46. Sillevis SP, Kinoshita A, De Leeuw B, et al. Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor. N Engl J Med. 2000;342(1):21-27.
47. Carr I. The Ophelia syndrome: memory loss in Hodgkin's disease. Lancet. 1982;1(8276):844-845.
48. Dale RC, Merheb V, Pillai S, et al. Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders. Brain. 2012;135(11):3453-3468.
49. Titulaer M, Hoftberger R, Iizuka T, et al. Overlapping demyelinating syndromes and anti-NMDA receptor encephalitis. Ann Neurol, in press.
50. Schleede L, Bueter W, Baumgartner-Sigl S, et al. Pediatric herpes simplex virus encephalitis: a retrospective multicenter experience. J Child Neurol. 2013;28(3):321-331.
51. Skoldenberg B, Aurelius E, Hjalmarsson A, et al. Incidence and pathogenesis of clinical relapse after herpes simplex encephalitis in adults. J Neurol. 2006;253(2):163-170.
52. Leypoldt F, Titulaer MJ, Aguilar E, et al. Herpes simplex virus-1 encephalitis can trigger anti-NMDA receptor encephalitis: case report. Neurology. 2013;81(18):1637-1639.
53. Hacohen Y, Deiva K, Pettingill P, et al. N-methyl-D-aspartate receptor antibodies in post-herpes simplex virus encephalitis neurological relapse. Mov Disord. 2014;29(1):90-96.
54. Armangue T, Leypoldt F, Malaga I, et al. Herpes simplex virus encephalitis is a trigger of brain autoimmunity. Ann Neurol. 2013. Dec 8. doi: 10.1002/ana.24083.
55. Dalmau J, Lancaster E, Martinez-Hernandez E, et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011;10(1):63-74.
56. Martinez-Hernandez E, Horvath J, Shiloh-Malawsky Y, et al. Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis. Neurology. 2011;77(6): 589-593.
57. Gable MS, Gavali S, Radner A, et al. Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. Eur J Clin Microbiol Infect Dis. 2009;28(12):1421-1429.
58. Gable MS, Sheriff H, Dalmau J, et al. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis. 2012;54(7):899-904.
59. Dale RC, Irani SR, Brilot F, et al. N-methyl-D-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica. Ann Neurol. 2009;66(5):704-709.